检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

A Phase 1 Study of KT-333, a Targeted Protein Degrader of STAT3, in Patients with Relapsed or Refractory Lymphomas, Large Granular Lymphocytic Leukemia, and Solid Tumors

Stephen D Smith,Alexander Starodub,Don A. Stevens,Aditi Shastri,Pierluigi Porcu,Tatyana Feldman,Reggie Ewesuedo,Chris DeSavi,Joyoti Dey,Sagar Agarwal,Sean Donohue,Rachelle Perea,Christine Klaus,Jared Gollob

Blood（2022）

引用 0|浏览8
暂无评分
关键词
stat3,targeted protein degrader,large granular lymphocytic leukemia,refractory lymphomas
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要